BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37904699)

  • 1. The role of inflammatory factors and T-cell subsets in the diagnosis of recurrence in epithelial ovarian cancer patients and the effect of olaparin treatment on them.
    Maowulieti G; Zhao S; Zhao M; Yuan H
    Immun Inflamm Dis; 2023 Oct; 11(10):e1059. PubMed ID: 37904699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of Correlation of Immune T Cell Subsets, TNF-α, IFN-γ and sFas levels with Severity and Prognosis in Aplastic Anemia Patients].
    Su AY; Yang XZ; Zhang MH; DI ZX; Li Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1459-1464. PubMed ID: 30295268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
    Dijkgraaf EM; Santegoets SJ; Reyners AK; Goedemans R; Wouters MC; Kenter GG; van Erkel AR; van Poelgeest MI; Nijman HW; van der Hoeven JJ; Welters MJ; van der Burg SH; Kroep JR
    Ann Oncol; 2015 Oct; 26(10):2141-9. PubMed ID: 26216383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
    Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
    Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
    Oza AM; Cibula D; Benzaquen AO; Poole C; Mathijssen RH; Sonke GS; Colombo N; Špaček J; Vuylsteke P; Hirte H; Mahner S; Plante M; Schmalfeldt B; Mackay H; Rowbottom J; Lowe ES; Dougherty B; Barrett JC; Friedlander M
    Lancet Oncol; 2015 Jan; 16(1):87-97. PubMed ID: 25481791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and T-lymphocyte subset, serum interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin-2(IL-2) levels on treatment of chronic aplastic anemia patients by shenfu injection combined with stanozol and cyclosporin A].
    Wang SY; Wei YF; Du HL; Ren LL; Li SH
    Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(5):383-5. PubMed ID: 15806975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer].
    Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects on the immune system and toxicity of carboplatin/paclitaxel combination chemotherapy in patients with stage III-IV ovarian and non small cell lung cancer and its role in survival and toxicity.
    Hatziveis K; Tourlakis D; Hountis P; Kyriazanos I; Sougleri M; Ginopoulos P; Camoutsis C
    J BUON; 2012; 17(1):143-8. PubMed ID: 22517709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
    Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
    Front Immunol; 2021; 12():773983. PubMed ID: 34777391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease].
    Mei JH; Tang G; Wang Q; Wen PQ; Xu MG; Cui D; Ma DL; Liu C; Wang GB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):791-798. PubMed ID: 29036979
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck.
    Norouzian M; Mehdipour F; Ashraf MJ; Khademi B; Ghaderi A
    BMC Immunol; 2022 Nov; 23(1):56. PubMed ID: 36376825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A.
    Cao Q; Batey R; Pang G; Russell A; Clancy R
    Immunol Cell Biol; 1998 Dec; 76(6):542-9. PubMed ID: 9893032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer.
    Kumar P; Ranmale S; Mehta S; Tongaonkar H; Patel V; Singh AK; Mania-Pramanik J
    J Ovarian Res; 2023 Jun; 16(1):114. PubMed ID: 37322531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
    Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
    Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment.
    McMullen M; Karakasis K; Loembe B; Dean E; Parr G; Oza AM
    Int J Gynecol Cancer; 2020 Nov; 30(11):1824-1828. PubMed ID: 32878963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
    Lee M; Kim SW; Nam EJ; Cho H; Kim JH; Kim YT; Kim S
    Yonsei Med J; 2014 Nov; 55(6):1664-71. PubMed ID: 25323906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Huangdisan grain on improving cognitive impairment in VD rats and its mechanism in immune inflammatory response.
    Wang Y; Zhi H; Zhang X
    J Neuroimmunol; 2023 Apr; 377():578058. PubMed ID: 36871311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.
    Dizon DS; Dupont J; Anderson S; Sabbatini P; Hummer A; Aghajanian C; Spriggs D
    Gynecol Oncol; 2003 Dec; 91(3):584-90. PubMed ID: 14675681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.